EHRC - Overview: Ehrlichia chaffeensis (HME) Antibody, IgG, Serum

An adjunct in the diagnosis of ehrlichiosis Seroepidemiological surveys of the prevalence of the infection in certain populations

GABA - Overview: Gabapentin, Serum

Monitoring serum gabapentin concentrations Assessing compliance Adjusting dosage in patients

PBCU - Overview: Lead/Creatinine Ratio, Urine

Detecting clinically significant lead exposure using random urine specimens This test is not a substitute for blood lead screening.

MPHNU - Overview: Methylphenidate and Metabolite, Random, Urine

Monitoring urine methylphenidate and ritalinic acid concentrations to assess compliance in patients

ITCON - Overview: Itraconazole, Serum

Verifying systemic absorption of orally administered itraconazole Patients with life-threatening fungal infections Patients considered at risk for poor absorption or rapid clearance of itraconazole

KRASW - Overview: KRAS Somatic Mutation Analysis, Peritoneal Fluid

Staging of the pancreatic ductal adenocarcinoma(1)

KINM - Overview: Ki-67(MIB-1), Gastrointestinal/Pancreatic Neuroendocrine Tumors, Quantitative Immunohistochemistry, Manual

Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with neuroendocrine tumors of the pancreas or gastrointestinal tract including metastases

IGGS4 - Overview: IgG4, Immunoglobulin Subclasses, Serum

Supporting the diagnosis of IgG4-related disease

INS - Overview: Insulin, Serum

Diagnosing insulinoma, when used in conjunction with proinsulin and C-peptide measurements Management of diabetes mellitus

AC1Q - Overview: Anti-C1q Antibodies, IgG, Serum

Evaluating patients with suspected anti-C1q vasculitis Predicting renal involvement in patients with systemic lupus erythematosus Detection of anti-C1q antibodies in serum

ALFP - Overview: Alpha-Fetoprotein (AFP) Immunostain, Technical Component Only

Aiding in the identification of yolk sac tumors and hepatocellular carcinoma

F_12 - Overview: Coagulation Factor XII Activity Assay, Plasma

Diagnosing deficiency of coagulation factor XII Determining cause of prolonged activated partial thromboplastin time

CYSR - Overview: Cystinuria Profile, Quantitative, Random, Urine

Biochemical diagnosis of cystinuria using random urine specimens

NCDTC - Overview: Neurochondrin Antibody, Tissue Immunofluorescence Titer, Spinal Fluid

Detecting neurochondrin-IgG in spinal fluid (CSF) from patients presenting with cerebellar and brainstem syndrome Reporting an end titer result from CSF specimens

OMHC - Overview: Oxcarbazepine Metabolite, Serum

Monitoring serum concentration during oxcarbazepine therapy Assessing compliance Assessing potential toxicity

MONOF - Overview: Monocyte Repartition by CD14/CD16, Blood

Aiding in the diagnosis and monitoring of chronic myelomonocytic leukemia

CSP53 - Overview: TP53 Gene Somatic Mutation Pre-Analysis Cell Sorting, Varies

Determination of B-cell content and confirmation the presence of a clonal B-cell population evaluating chronic lymphocytic leukemia patients prior to TP53 variant analysis

SFZ - Overview: Sulfamethoxazole, Serum

Monitoring sulfamethoxazole therapy to ensure drug absorption, clearance, or compliance

PLFAT - Overview: Cryptococcus Antigen Titer, Lateral Flow Assay, Pleural Fluid

Diagnosis of infection with Cryptococcus species

CXC13 - Overview: CXCL13 Immunostain, Technical Component Only

Assessment of CXCL13 (CXC motif chemokine ligand 13) expression

CEA - Overview: Carcinoembryonic Antigen (CEA), Serum

Monitoring colorectal cancer and selected other cancers such as medullary thyroid carcinoma May be useful in assessing the effectiveness of chemotherapy or radiation treatment This test is not useful for screening the general population...

CDOU - Overview: Cadmium Occupational Exposure, Random, Urine

Detecting occupational exposure to cadmium using random urine specimens

CD15 - Overview: CD15 Immunostain, Technical Component Only

Phenotyping leukemias and lymphomas

CALNN - Overview: Calretinin Immunostain, Technical Component Only

Separating mesotheliomas from carcinomas which usually lack expression of calretinin

DULOX - Overview: Duloxetine, Serum

Monitoring duloxetine serum concentration during therapy Evaluating potential duloxetine toxicity Evaluating patient compliance

ETGS - Overview: Ethyl Glucuronide Screen, Random, Urine

Screening for drug abuse involving alcohol

OLIGC - Overview: Oligoclonal Banding, Spinal Fluid

Diagnosis of multiple sclerosis; especially useful in patients with equivocal clinical presentation and radiological findings

F_7 - Overview: Coagulation Factor VII Activity Assay, Plasma

Diagnosing congenital deficiency of coagulation factor VII Evaluating acquired deficiencies associated with liver disease, oral anticoagulant therapy, and vitamin K deficiency Determining degree of anticoagulation with warfarin to...

VANTA - Overview: Vancomycin, Trough, Serum

Preferred test for monitoring vancomycin therapy Monitoring trough concentrations drawn at steady-state in selected patients receiving vancomycin therapy

VANRA - Overview: Vancomycin, Random, Serum

Monitoring adequacy of drug concentration during vancomycin therapy whenever a specimen is submitted or collected without collection timing information

SMOTH - Overview: Smoothelin Immunostain, Technical Component Only

Distinguishing muscularis mucosae from muscularis propria

CALX - Overview: CALR Mutation Analysis, Myeloproliferative Neoplasm (MPN), Reflex, Varies

Aiding in the distinction between a reactive cytosis and a chronic myeloproliferative disorder Evaluating mutations in CALR in an algorithmic process for the MPNR / Myeloproliferative Neoplasm, JAK2 V617F with Reflex to CALR and MPL,...

THCM - Overview: 11-nor-Delta-9-Tetrahydrocannabinol-9-Carboxylic Acid (Carboxy-THC) Confirmation, Meconium

Detecting in utero drug exposure to marijuana (tetrahydrocannabinol) up to 5 months before birth

PTU - Overview: Protein, Total, 24 Hour, Urine

Evaluation of kidney disease using a 24-hour urine collection Screening for monoclonal gammopathy

BILID - Overview: Bilirubin Direct, Serum

Evaluation of jaundice and liver functions

SULFU - Overview: Sulfate, 24 Hour, Urine

Assessing the nutrition intake of animal protein The calculation of urinary supersaturation of various crystals or stones

SASP - Overview: Aspergillus fumigatus, IgG Antibodies, Serum

Evaluation of patients suspected of having hypersensitivity pneumonitis (HP) induced by exposure to Aspergillus fumigatus Evaluation of patients suspected of having HP who have documented environmental exposures to high-humidity...

F8IS - Overview: Coagulation Factor VIII Inhibitor Screen, Plasma

Detecting the presence of a specific factor inhibitor directed against coagulation factor VIII

ENC2 - Overview: Encephalopathy, Autoimmune/Paraneoplastic Evaluation, Spinal Fluid

Evaluating new onset encephalopathy (noninfectious or metabolic) comprising confusional states, psychosis, delirium, memory loss, hallucinations, movement disorders, sensory or motor complaints, seizures, dyssomnias, ataxias, nausea,...

RBCS - Overview: Relative B-Cell Subset Analysis Percentage, Blood

Screening for humoral or combined immunodeficiencies, including common variable immunodeficiency, hyper IgM syndrome, among others, where B-cell subset distribution information is desired Assessing B-cell subset reconstitution after...

SHPV - Overview: Human Papillomavirus (HPV) DNA Detection with Genotyping, High-Risk Types by PCR, SurePath, Varies

Detection of high-risk (HR) genotypes associated with the development of cervical cancer An aid in triaging women with abnormal Pap smear test results Individual genotyping of human papillomavirus (HPV)-16 and/or HPV-18, if present...

DICET - Overview: DICER1 Mutation Analysis, Next-Generation Sequencing, Tumor

Identifying specific mutations within the DICER1 gene to assist in tumor diagnosis/classification

F822B - Overview: Hemophilia A F8 Gene, Intron 22 Inversion Known Mutation, Whole Blood

First-tier molecular testing for male patients affected with severe hemophilia A, when a familial intron 22 inversion has been previously identified Determining hemophilia A carrier status for at-risk female patients, ie, individuals with...

HISGT - Overview: Histone Genes Mutation Analysis, Next-Generation Sequencing, Tumor

Identifying specific mutations within the H3-3A, H3-3B, H3C2, H3C3 and H3C14 genes that assist in tumor diagnosis/classification

WILMP - Overview: Hereditary Wilms Tumor Panel, Varies

Evaluating isolated and syndromic causes of Wilms tumor Establishing a diagnosis to guide management for individuals with Wilms tumor Identifying a familial variant allowing for predictive testing and appropriate screening of at-risk...

F81P - Overview: Hemophilia A F8 Gene, Intron 1 Inversion Known Mutation Analysis, Prenatal

Prenatal testing for hemophilia A when a F8 intron 1 inversion has been identified in a family member

GALMP - Overview: Galactosemia, GALT Gene, Variant Panel, Varies

Second-tier test for confirming a diagnosis of galactosemia as indicated by enzymatic testing or newborn screening Carrier testing family members of an affected individual of known genotype (has variants included in the panel) Resolution...

ESR1T - Overview: ESR1 Mutation Analysis, Next-Generation Sequencing, Tumor

Assisting in the clinical management of patients with metastatic breast cancer by identifying tumors with evolving resistance to endocrine therapy Stratifying prognosis of metastatic breast cancer

INHAB - Overview: Inhibin A and B, Tumor Marker, Serum

Aiding in the diagnosis of granulosa cell tumors and mucinous epithelial ovarian tumors Monitoring of patients with granulosa cell tumors and epithelial mucinous-type tumors of the ovary known to secrete inhibin A or overexpress inhibin B

MCCRC - Overview: MayoComplete Colorectal Cancer Panel, Next-Generation Sequencing, Tumor

Primarily for determining patient response to various targeted therapies/immunotherapy Predicting prognosis from microsatellite instability status